This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Entain PLC | 530.0 | 5.2% |
| Pershing Square Holdings LTD | 3,630.0 | 4.1% |
| Vodafone Group PLC | 73.2 | 4.0% |
| Barclays PLC | 216.0 | 3.8% |
| Natwest Group PLC | 334.1 | 3.4% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Wpp PLC | 701.6 | -2.2% |
| Intercontinental Hotels Group PLC | 7274.0 | -1.8% |
| Coca-Cola Hbc AG | 2692.0 | -1.8% |
| Easyjet PLC | 420.9 | -0.8% |
| Antofagasta PLC | 1816.0 | -0.3% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 8,167 | 1.8% | 8.5% |
| DOW JONES INDUS. AVG | 38,763 | -0.6% | 9.8% |
| DAX INDEX | 17,615 | 1.5% | 11.7% |
| NIKKEI 225 | 34,805 | -0.8% | 7.4% |
| S&P/ASX 200 INDEX | 7,682 | -0.2% | 4.6% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 75.17 | -0.08% |
| Brent Crude (ICE) | USD/bbl. | 78.16 | -0.22% |
| Gold Spot | USD/t oz. | 2,394 | 0.5% |
| Copper (Comex) | USd/lb. | 396 | 0.2% |
Click graph to enlarge
The UK 100 called to open -52 points at 8,125. The UK 100 looks set to open lower this morning ahead of today’s US weekly jobless claims data, amid recession fears for the worlds largest economy. Stocks closed lower Stateside on Wednesday, having started the session significantly higher as the market’s attempt to fully recover from Monday’s sell-off failed. The Dow Jones fell 234.21 points, or 0.60%, to 38,763.45. The S&P declined 0.77% and ended at 5,199.50, while the Nasdaq dropped 1.05% to close at 16,195.81. In Asia, Japan’s Nikkei 225 index is 0.7% lower but the Hang Seng index and Shanghai Composite are moderately higher.
Barratt Developments & Redrow: UK CMA says the Barratt & Redrow merger does not raise UK-wide competition concerns, just a competition concern in one area.
Entain have raised their annual net gaming revenue and earnings forecast after better-than-expected Q2 performance and easing regulatory pressures in Brazil and the Netherlands. They see their FY group EBITDA being between £1,040-1,090m.
Hikma Pharmaceuticals report a H1 pretax profit of $288m, up from $202m YoY. They have increased their H1 dividend to 32 cents per share, up from 25 cents per share YoY as their outlook for 2024 is strong. They have upped their revenue growth guidance and operating profit guidance as the business has performed “extremely well”.
Persimmon posted a drop in interim pretax profit, but have forecast their annual home build target at the top-end of its forecast range as easing mortgage rates and UK rate cuts boost recovery hopes in the homebuilding sector. They reported a H1 adjusted operating profit of £152.3m.
HSBC Downgrades BP to Hold from Buy (6 Buys / 5 Holds / 1 Sell)
UK
Beazley
Derwent London
Entain
Harbour Energy
Helios Towers
Hikma Pharmaceuticals
Hill & Smith Holdings
Lancashire Holdings
Morgan Sindall
Page Group
Persimmon
Savills*
Spirax Group
TI Fluid Systems
US
Eli Lilly and Co
Viatris
Gilead Sciences
Take-Two Interactive Software
The Trade Desk
Unity Software
UK
Bellway
Hargreaves Lansdown
Hiscox
TBC Bank Group
US
None
US Initial Jobless Claims
UK 100 companies going ex-dividend on 8th August 2024:
BT Group
Ashtead Group
Informa
Unilever
AstraZeneca
Rentokil Initial
NatWest Group
IMI
SEGRO
Pearson
BP
Standard Chartered
Fresnillo
Melrose Industries
UK 250 companies going ex-dividend on 8th August 2024:
Monks Investment Trust
Jupiter Fund Management
Man Group
GCP Infrastructure Investments
Aberforth Smaller Companies Trust
Games Workshop Group
Inchcape
Scottish American Investment Company
Vesuvius
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.